Crewe Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141M Buy
3,307,188
+553,009
+20% +$19.9M 10.22% 2
2026
Q1
$88.5M Buy
2,754,179
+606,364
+28% +$22.3M 7.55% 2
2025
Q4
$82.5M Buy
2,147,815
+1,035,747
+93% +$22.7M 7.3% 2
2025
Q3
$15.3M Hold
1,112,068
1.46% 19
2025
Q2
$14.4M Hold
1,112,068
2.03% 15
2025
Q1
$12.5M Hold
1,112,068
1.76% 14
2024
Q4
$14.6M Buy
1,112,068
+1,110,410
+66,973% +$28.5M 2.01% 16
2024
Q3
$66.3K Buy
+1,658
New +$60.3K 0.01% 272

Other funds holding PACS

Crewe Advisors's PACS Position: Q2 2026 in Review

Crewe Advisors increased its PACS Group (PACS) stake by 20% in Q2 2026, buying an estimated $19.9M and bringing the position to 3,307,188 shares worth $141M. The position accounts for 10.22% of the portfolio, ranked #2.

Crewe Advisors first reported a position in PACS in Q3 2024 and has held it in 8 quarters since. 81 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Crewe Advisors held 3,307,188 shares of PACS Group worth $141M as of Q2 2026.
  • Crewe Advisors bought 553,009 PACS Group shares in Q2 2026, an estimated $19.9M.
  • PACS Group made up 10.22% of Crewe Advisors's portfolio in Q2 2026, its #2 holding.
  • Crewe Advisors first reported a position in PACS Group in Q3 2024 and has held it in 8 quarters since.
  • 81 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.